Menu

• Ask a Health Expert about RESTRICTIVE CARDIOMYOPATHY
• Post Your Side Effect related to RESTRICTIVE CARDIOMYOPATHY
• RESTRICTIVE CARDIOMYOPATHY and FDA Warnings
• RESTRICTIVE CARDIOMYOPATHY in Patients Wiki
• Report RESTRICTIVE CARDIOMYOPATHY in Drug Side Effect Survey

RESTRICTIVE CARDIOMYOPATHY side effect

What is RESTRICTIVE CARDIOMYOPATHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Zyprexa Side Effects Report #5376418-X
Consumer or non-health professional from UNITED STATES reported ZYPREXA problem on June 20, 2007. Female patient, 83 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: hypertension, restrictive cardiomyopathy, type 2 diabetes mellitus, weight increased, . ZYPREXA dosage: 5 MG, UNK. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.

Zyprexa Side Effects Report #5376418-X
ZYPREXA problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 83 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: hypertension, restrictive cardiomyopathy, type 2 diabetes mellitus, weight increased, . ZYPREXA dosage: 5 MG, UNK. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.

Chloroquine Side Effects Report #5660603-3
Physician from SPAIN reported CHLOROQUINE PHOSPHATE problem on Feb 29, 2008. Male patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with CHLOROQUINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, bundle branch block, restrictive cardiomyopathy, . CHLOROQUINE PHOSPHATE dosage: 250 MG, DAILY X 6 YEARS, ORAL. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Viagra Side Effects Report #5457766-1
VIAGRA problem was reported by a Consumer or non-health professional from DENMARK on Sept 06, 2007. Male patient, 41 years of age, was diagnosed with erectile dysfunction and was treated with VIAGRA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, cardiac hypertrophy, restrictive cardiomyopathy, syncope, troponin t increased, ventricular tachycardia, . VIAGRA dosage: unknown. Patient was hospitalized. Patient recovered.


Arava Side Effects Report #5704269-2
Physician from ROMANIA reported ARAVA problem on Apr 04, 2008. Female patient, 49 years of age, weighting 116.8 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: eosinophilia, intracardiac thrombus, restrictive cardiomyopathy, . ARAVA dosage: unknown. During the same period patient was treated with NSAID. Patient was hospitalized. Patient recovered.

Arava Side Effects Report #5712640-8
ARAVA problem was reported by a Physician from ROMANIA on Apr 14, 2008. Female patient, 49 years of age, weighting 116.8 lb, was diagnosed with rheumatoid arthritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: eosinophilia, intracardiac thrombus, restrictive cardiomyopathy, . ARAVA dosage: unknown. During the same period patient was treated with NSAID. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5262523-5
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on Feb 26, 2007. Male patient, 75 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, dyspnoea exertional, restrictive cardiomyopathy, . IMATINIB MESYLATE dosage: 400 MG, QD. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, OMEPRAZOLE, BISOPROLOL, ATORVASTATIN. Patient recovered.